Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

212,521-212,550 of 319,975

filter-aware
16
The slide presents two distinct tables: one for cash flow (left) and one for net debt (right).Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · Financials1 hit
17
The forecast range is SEK 7,000 – 9,000 million.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
18
The background image is highly stylized and dark, contrasting with the simple, bold white text.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
Embracer Group | Results Presentation Deck | 25 slidesEmbracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
20
The slide outlines specific financial targets for the Embracer Group restructuring program.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a horizontal bar chart style to represent a phased timeline.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
Part of a Q1 update presentation for Embracer Group.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
23
The background features a stylized 'A' shape composed of various photos of employees/work environments.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
24
Embracer Group | Results Presentation Deck | 25 slidesEmbracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
25
Embracer Group | Results Presentation Deck | 25 slidesEmbracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
01
Slide 1
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
02
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
03
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
04
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
05
The slide uses a visual metaphor of donor vs patient cells to explain the mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
06
The slide uses a chevron-based process flow to map disease states to market validation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
07
The slide uses a flow-based diagram to show how pipeline assets are developed and then monetized through various business strategies.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-style timeline to show progress of various therapeutic programs.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
09
The slide uses a card-based layout to display five key executives with their titles and previous company affiliations.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
10
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
11
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
12
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
13
The slide uses a quote from a subject matter expert to build credibility.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
14
The slide uses a biological process diagram to illustrate the mechanism of immune activation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide uses a visual comparison to illustrate two distinct evasion strategies: starving killer T-cells and recruiting protective T-reg cells.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
16
The diagram uses a callout-style list to map specific cellular functions to a central dendritic cell illustration.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution1 hit
17
The slide uses a circular process flow to represent the manufacturing cycle of a personalized cell therapy.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution1 hit
18
Includes statistical significance markers (p-values) and sample sizes (n).Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The slide acts as a pointer to a specific external scientific presentation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
The slide uses a ribbon-style process diagram to show progression.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit